TGFB1 and neoplasm: In this regard, TGF-β inhibition (NCT02423343 and NCT04064190 are ongoing trials), radiotherapy, or chemotherapy plus ICB can be utilized to change a non-inflamed malignancy into an inflamed one and further stimulate the dampened anti-tumor immunity (51).